Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $126.39M.
ENTERPRISE VALUE (EV)
$126.39M
Fortress Biotech, Inc.
Market Cap
$146.27M
Enterprise Value (EV)
$126.39M
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Fortress Biotech, Inc. (FBIOP) | $146.27M | $126.39M |
| Codexis, Inc. (CDXS)vs › | $146.28M | $191.70M |
| Acumen Pharmaceuticals, Inc. (ABOS)vs › | $146.62M | $118.75M |
| Anavex Life Sciences Corp. (AVXL)vs › | $148.27M | $29.95M |
| Voyager Therapeutics, Inc. (VYGR)vs › | $148.64M | $145.43M |
| NervGen Pharma Corp. Common stock (NGEN)vs › | $143.84M | $82.64M |
| Korsana Biosciences, Inc. (KRSA)vs › | $148.73M | $147.34M |
| Protara Therapeutics, Inc. (TARA)vs › | $143.60M | $129.27M |
| ALX Oncology Holdings Inc. (ALXO)vs › | $149.36M | $136.38M |
| Nyxoah S.A. (NYXH)vs › | $143.10M | $129.92M |
Market Cap
$146.27M
Total Debt
$59.50M
Cash
$79.38M
Enterprise Value
$126.39M
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
